LB Pharmaceuticals Inc · NASDAQ:LBRX
Commodore Capital LP reported a 5.80% stake in LB Pharmaceuticals Inc (Schedule 13G/A)
Event Sep 30, 2026 · Filed Nov 16, 2026
Commodore Capital LP reported a 5.80% stake in LB Pharmaceuticals Inc, 1,897,745 shares, as a passive investor on Sep 30, 2026. Filed Nov 16, 2026 (Schedule 13G/A).
- Stake
- 5.80%
- Shares
- 1,897,745
- Intent
- Passive
- What changed
- Stake changed
- Filed together
- 4 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Commodore Capital LP | 5.80% | 1,897,745 |
| Commodore Capital Master LP | 5.80% | 1,897,745 |
| Robert Egen Atkinson | 5.80% | 1,897,745 |
| Michael Kramarz | 5.80% | 1,897,745 |
Source
Download original · View original at SEC
Related
- LB Pharmaceuticals Inc
- Commodore Capital LP
- LB Pharmaceuticals Inc shareholders
- Schedule 13G/A · Commodore Capital LP · May 15, 2026
- Schedule 13G · Commodore Capital LP · Sep 18, 2025
- Schedule 13G/A · Trails Edge Capital Partners, LP · Nov 16, 2026
- Schedule 13G/A · TCG Crossover GP II, LLC · Nov 16, 2026
- Schedule 13G/A · JPMorgan Chase & Co · Oct 13, 2026
- Schedule 13G/A · TCG Crossover GP II, LLC · Aug 14, 2026
- Schedule 13G/A · BlackRock, Inc. · Jul 29, 2026